Valuation: Inventage Lab, Inc.

Market Cap	33TCr 25Cr 22Cr 21Cr 19Cr 35Cr 2.39TCr 36Cr 249.68Cr 98Cr 1.25TCr 95Cr 93Cr 3.96TCr	P/E 2024	-11.5x	P/E 2025	-110x
Enterprise Value	33TCr 25Cr 22Cr 20Cr 19Cr 35Cr 2.35TCr 35Cr 245.7Cr 97Cr 1.23TCr 93Cr 91Cr 3.9TCr	EV / Sales 2024	106x	EV / Sales 2025	356x
Free-Float	73.05%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news: Inventage Lab, Inc.

16/03	Quratis Inc. announced that it has received KRW 10.000000167 billion in funding from Inventage Lab, Inc.	CI
16/03	Inventage Lab, Inc. announced that it has received KRW 89.99724455 billion in funding from a group of investors	CI
09/03	Inventage Lab, Inc. announced that it has received KRW 8.5 billion in funding	CI
06/03	Inventage Lab, Inc. announced that it expects to receive KRW 37.25 billion in funding from a group of investors	CI
06/03	Inventage Lab, Inc. announced that it expects to receive KRW 8.5 billion in funding	CI
06/03	Inventage Lab, Inc. announced that it expects to receive KRW 52.74724455 billion in funding from a group of investors	CI
06/03	Quratis Inc. announced that it expects to receive KRW 10.000000167 billion in funding from Inventage Lab, Inc.	CI
26/02	Inventage Lab, Inc. agreed to acquire an additional 12.79% stake in Quratis Inc. for KRW 13.5 billion.	CI
10/12	Inventage Lab Seeks Approval for Phase 2 Trial of Alopecia Drug in Australia	MT
22/25/22	Inventage Lab, Inc.(KOSDAQ:A389470) added to S&P Global BMI Index	CI
12/25/12	Inventage Lab, Inc. announced that it has received KRW 9.9999925 billion in funding from PEACE to S KOREA Co., Ltd	CI
12/25/12	Quratis Inc. announced that it has received KRW 10.0329 billion in funding from Inventage Lab, Inc.	CI
21/25/21	Quratis Inc. announced that it has received KRW 15 billion in funding from Inventage Lab, Inc.	CI

More news

Managers and Directors: Inventage Lab, Inc.

Manager	Title	Age	Since
Ju-Hee Kim CEO	Chief Executive Officer	52	14/05/2015
Byeong-Yul Jeong DFI	Director of Finance/CFO	55	-
Chan-Hee Jeon CTO	Chief Tech/Sci/R&D Officer	57	-

Director	Title	Age	Since
Ju-Hee Kim BRD	Director/Board Member	52	14/05/2015
Choong-Ho Ryu BRD	Director/Board Member	56	-
Dong-Hoon Kim BRD	Director/Board Member	56	-

More insiders

Inventage Lab Inc is a Korea-based company principally engaged in the pharmaceutical business. The Company owns the platforms applied to the development and mass production of long-acting injections and drug delivery of genetic materials. The Company is engaged in the research, manufacture and sale of human medicines used for male pattern baldness, dementia, prostate cancer and others. It is also engaged in the research, manufacture and sale of veterinary medicines such as combination drugs, chemical castration agents and others.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
22/26/22	₩25,100.00	-4.20%	84,901
21/26/21	₩26,200.00	+4.38%	1,00,067
20/26/20	₩25,100.00	-0.20%	55,813
19/26/19	₩25,150.00	+1.62%	50,838
16/26/16	₩24,750.00	+2.48%	1,50,594

End-of-day quote Korea S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. 22/10/2026			5-day change	1st Jan Change
25,100.00 ^KRW	-4.20%		-5.99%	-70.19%

1 day	-4.20%
1 week	-5.99%
Current month	-2.71%
1 month	-2.14%
3 months	-18.77%
6 months	-58.92%
Current year	-70.19%

1 week	23,500	27,500
1 month	22,550	34,000
Current year	22,550	1,01,700
1 year	22,550	1,01,700
3 years	9,400	1,01,700
5 years	8,440	1,01,700
10 years	8,440	1,01,700

Date	Insider	Type	Quantity	% Market Cap.
08/08/25	Dong Seok Park	Exercice	8,000	0.0796%
08/08/25	Se Yeon Kim	Exercice	10,000	0.0996%
08/08/25	Dong Seok Park	Exercice	8,000	0.0796%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INVENTAGE LAB, INC.	-4.20%	-5.99%	-33.42%	+51.94%	26Cr
ELI LILLY AND COMPANY	+2.83%	+8.10%	+63.42%	+123.50%	1,13300Cr
JOHNSON & JOHNSON	+3.81%	+5.40%	+39.47%	+74.91%	62TCr
ABBVIE INC.	+0.14%	+0.60%	+23.25%	+95.03%	50TCr
ROCHE HOLDING AG	+0.03%	+5.72%	+39.64%	+64.06%	38TCr
MERCK & CO., INC.	-1.76%	-0.09%	+68.04%	+43.41%	37TCr
NOVARTIS AG	+1.58%	+5.07%	+23.26%	+51.98%	29TCr
ASTRAZENECA PLC	+2.90%	+5.53%	+4.06%	+24.45%	26TCr
AMGEN INC.	+2.04%	+4.97%	+48.53%	+60.42%	24TCr
GILEAD SCIENCES, INC.	+2.36%	+2.38%	+26.68%	+102.04%	19TCr
Average	+0.47%	+3.04%	+30.29%	+69.17%	39.88TCr
Weighted average by Cap.	+0.48%	+3.73%	+43.30%	+82.73%

Inventage Lab, Inc. Share Price

Stocks

A389470

KR7389470006

Pharmaceuticals

Valuation: Inventage Lab, Inc.

Chart: Inventage Lab, Inc.

Latest news: Inventage Lab, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Inventage Lab, Inc.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

	2024	2025
Net sales	178.29Cr 13.44L 12L 11.04L 10.06L 18.85L 13Cr 19.17L 1.33Cr 52.47L 6.69Cr 50.47L 49.4L 21Cr	293.88Cr 22.16L 19.78L 18.19L 16.57L 31.06L 21Cr 31.59L 2.2Cr 86.49L 11Cr 83.2L 81.43L 35Cr
Net income	-1.7TCr -1.28Cr -1.14Cr -1.05Cr -95.86L -1.8Cr -121.58Cr -1.83Cr -13Cr -5Cr -64Cr -4.81Cr -4.71Cr -201.57Cr	-845.84Cr -63.78L -56.92L -52.36L -47.71L -89.4L -61Cr -90.93L -6.32Cr -2.49Cr -32Cr -2.39Cr -2.34Cr -100.31Cr
Net Debt	-2.4TCr -1.81Cr -1.61Cr -1.48Cr -1.35Cr -2.53Cr -171.43Cr -2.58Cr -18Cr -7.05Cr -90Cr -6.78Cr -6.64Cr -284.21Cr	-532.71Cr -40.17L -35.85L -32.97L -30.04L -56.31L -38Cr -57.27L -3.98Cr -1.57Cr -20Cr -1.51Cr -1.48Cr -63Cr